Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-10 Sale | 2021-08-11 6:20 pm | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $29.86 | $223,926 | 127,558 (Indirect Direct) | View |
| 2021-07-12 Sale | 2021-07-12 7:36 pm | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $23.92 | $179,419 | 135,058 (Indirect Direct) | View |
| 2021-06-10 Sale | 2021-06-11 4:10 pm | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $29.37 | $220,248 | 142,558 (Indirect Direct) | View |
| 2021-05-10 Sale | 2021-05-11 7:56 pm | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $26.49 | $198,644 | 150,058 (Indirect Direct) | View |
| 2021-04-12 Sale | 2021-04-13 5:19 pm | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $27.28 | $204,632 | 157,558 (Indirect Direct) | View |
| 2021-03-08 Sale | 2021-03-09 4:04 pm | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $37.02 | $277,678 | 123,392 (Indirect Direct) | View |
| 2021-02-18 Sale | 2021-02-22 4:06 pm | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 15,000 | $35.49 | $532,352 | 101,773 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-08-10 Exercise | 2021-08-11 6:20 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $1.11 | 127,558 (Direct) | View |
| 2021-08-10 Exercise | 2021-08-11 6:20 pm | N/A 2027-02-01 | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $0 | 127,558 (Direct) | View |
| 2021-07-12 Exercise | 2021-07-12 7:36 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $1.11 | 135,058 (Direct) | View |
| 2021-07-12 Exercise | 2021-07-12 7:36 pm | N/A 2027-02-01 | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $0 | 135,058 (Direct) | View |
| 2021-06-10 Exercise | 2021-06-11 4:10 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $1.11 | 142,558 (Direct) | View |
| 2021-06-10 Exercise | 2021-06-11 4:10 pm | N/A 2027-02-01 | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $0 | 142,558 (Direct) | View |
| 2021-05-10 Exercise | 2021-05-11 7:56 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $1.11 | 150,058 (Direct) | View |
| 2021-05-10 Exercise | 2021-05-11 7:56 pm | N/A 2027-02-01 | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $0 | 150,058 (Direct) | View |
| 2021-04-12 Exercise | 2021-04-13 5:19 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 5,104 | $1.11 | 157,558 (Direct) | View |
| 2021-04-12 Exercise | 2021-04-13 5:19 pm | N/A 2026-01-27 | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $0 | 157,558 (Direct) | View |
| 2021-04-12 Exercise | 2021-04-13 5:19 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 2,396 | $0.84 | 157,558 (Direct) | View |
| 2021-03-25 Exercise | 2021-03-25 7:23 pm | N/A 2026-01-27 | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 4,330 | $0 | 123,392 (Direct) | View |
| 2021-03-25 Exercise | 2021-03-25 7:23 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 4,330 | $0.84 | 123,392 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-09 4:04 pm | N/A 2026-01-27 | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $0 | 123,392 (Direct) | View |
| 2021-03-08 Exercise | 2021-03-09 4:04 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 7,500 | $0.84 | 123,392 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 4:06 pm | N/A 2026-01-27 | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 15,000 | $0 | 101,773 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 4:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 9,107 | $0.84 | 101,773 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 4:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 3,797 | $7.26 | 101,773 (Direct) | View |
| 2021-02-18 Exercise | 2021-02-22 4:06 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 2,096 | $9.57 | 101,773 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-12 7:21 pm | N/A 2031-02-10 | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 40,000 | $0 | 40,000 (Direct) | View |
Ownership | 2020-07-23 6:48 pm | N/A N/A | Nurix Therapeutics Inc. | NRIX | Beaurang Pierre Chief Business Officer | 0 | $0 | 391,771 (Indirect) | View |